• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丙戊酸的游离分数:体外随时间增加及其与人体血浆和血清中游离脂肪酸浓度的相关性。

Free fraction of valproic acid: in vitro time-dependent increase and correlation with free fatty acid concentration in human plasma and serum.

作者信息

Albani F, Riva R, Procaccianti G, Baruzzi A, Perucca E

出版信息

Epilepsia. 1983 Feb;24(1):65-73. doi: 10.1111/j.1528-1157.1983.tb04867.x.

DOI:10.1111/j.1528-1157.1983.tb04867.x
PMID:6401631
Abstract

The effect of sample incubation and storage on the protein binding of the antiepileptic drug valproic acid (VPA) and on the concentration of free fatty acids (FFA) was investigated in serum and plasma collected from four normal volunteers. Both the free fraction of VPA and the concentration of FFA increased progressively with time when samples were incubated at 4 to 37 degrees C. These effects occurred to the same extent in both serum and heparinized plasma. At 4 degrees C and at room temperature, the increase in free drug fraction was relatively small (18 and 25% respectively at 24 h), whereas at 37 degrees C it was quite considerable (24% at 8 h and 40% at 24 h). At room temperature, FFA rose on average by 22% at 4 h, 34% at 8 h, and 86% at 24 h, whereas at 37 degrees C the increases at the same incubation times were 59, 90, and 160%, respectively. There was a strong positive relationship between changes in free VPA fraction and FFA content of the samples. The time-dependent changes in VPA binding capacity described in this study may lead to overestimation of the actual free concentration in vivo, especially when this is estimated by equilibrium dialysis or ultracentrifugation techniques requiring long incubation (centrifugation) times at 37 degrees C.

摘要

在从四名正常志愿者采集的血清和血浆中,研究了样品孵育和储存对抗癫痫药物丙戊酸(VPA)的蛋白质结合以及游离脂肪酸(FFA)浓度的影响。当样品在4至37摄氏度下孵育时,VPA的游离分数和FFA的浓度均随时间逐渐增加。血清和肝素化血浆中的这些影响程度相同。在4摄氏度和室温下,游离药物分数的增加相对较小(24小时时分别为18%和25%),而在37摄氏度时则相当可观(8小时时为24%,24小时时为40%)。在室温下,FFA在4小时时平均升高22%,8小时时升高34%,24小时时升高86%,而在37摄氏度下,相同孵育时间的升高分别为59%、90%和160%。样品中游离VPA分数的变化与FFA含量之间存在很强的正相关关系。本研究中描述的VPA结合能力的时间依赖性变化可能导致对体内实际游离浓度的高估,尤其是当通过平衡透析或超速离心技术进行估计时,这些技术需要在37摄氏度下长时间孵育(离心)。

相似文献

1
Free fraction of valproic acid: in vitro time-dependent increase and correlation with free fatty acid concentration in human plasma and serum.丙戊酸的游离分数:体外随时间增加及其与人体血浆和血清中游离脂肪酸浓度的相关性。
Epilepsia. 1983 Feb;24(1):65-73. doi: 10.1111/j.1528-1157.1983.tb04867.x.
2
Determination of unbound valproic acid concentration in plasma by equilibrium dialysis and gas--liquid chromatography: methodological aspects and observations in epileptic patients.
Ther Drug Monit. 1982;4(4):341-52. doi: 10.1097/00007691-198212000-00003.
3
Protein binding of valproic acid in the presence of elevated free fatty acids in patient and normal human serum.
Epilepsia. 1981 Feb;22(1):11-7. doi: 10.1111/j.1528-1157.1981.tb04328.x.
4
Mechanism of altered drug binding to serum proteins in pregnant women: studies with valproic acid.
Ther Drug Monit. 1984;6(1):25-30. doi: 10.1097/00007691-198403000-00006.
5
The influence of free fatty acids on valproic acid plasma protein binding during fasting in normal humans.正常人体空腹状态下游离脂肪酸对丙戊酸血浆蛋白结合的影响。
Eur J Clin Pharmacol. 1982 Oct;23(4):343-7. doi: 10.1007/BF00613618.
6
Serum protein binding of phenytoin and valproic acid in insulin-dependent diabetes mellitus.
Ther Drug Monit. 1987 Dec;9(4):389-91. doi: 10.1097/00007691-198712000-00005.
7
Nonlinear binding of valproic acid (VPA) and E-delta 2-valproic acid to rat plasma proteins.丙戊酸(VPA)和E-δ2-丙戊酸与大鼠血浆蛋白的非线性结合
Pharm Res. 1990 May;7(5):461-7. doi: 10.1023/a:1015804413818.
8
Valproic acid in the perinatal period: decreased maternal serum protein binding results in fetal accumulation and neonatal displacement of the drug and some metabolites.
J Pediatr. 1984 Apr;104(4):627-34. doi: 10.1016/s0022-3476(84)80567-3.
9
Serum protein binding of valproic acid in healthy subjects and in patients with liver disease.
Int J Clin Pharmacol Ther Toxicol. 1981 Jul;19(7):319-25.
10
Serum protein binding of valproic acid in fetus-mother pairs throughout pregnancy: correlation with oxytocin administration and albumin and free fatty acid concentrations.孕期胎儿-母体对中丙戊酸的血清蛋白结合:与催产素给药以及白蛋白和游离脂肪酸浓度的相关性。
J Clin Pharmacol. 1986 Mar;26(3):215-21. doi: 10.1002/j.1552-4604.1986.tb02937.x.

引用本文的文献

1
Pharmacokinetic Factors to Consider in the Selection of Antiseizure Drugs for Older Patients with Epilepsy.老年癫痫患者抗癫痫药物选择中需考虑的药代动力学因素。
Drugs Aging. 2018 Aug;35(8):687-698. doi: 10.1007/s40266-018-0562-2.
2
Pharmacokinetic considerations in the treatment of childhood epilepsy.
Paediatr Drugs. 2003;5(4):267-77. doi: 10.2165/00128072-200305040-00005.
3
SPECT in the localisation of extratemporal and temporal seizure foci.单光子发射计算机断层扫描在颞叶外和颞叶癫痫病灶定位中的应用
J Neurol Neurosurg Psychiatry. 1995 Jul;59(1):26-30. doi: 10.1136/jnnp.59.1.26.
4
Rationale for monitoring free drug levels.监测游离药物水平的基本原理。
Clin Pharmacokinet. 1984 Jan;9 Suppl 1:1-9. doi: 10.2165/00003088-198400091-00001.
5
In vivo plasma protein binding interaction between valproic acid and naproxen.丙戊酸与萘普生在体内的血浆蛋白结合相互作用。
Eur J Drug Metab Pharmacokinet. 1984 Oct-Dec;9(4):359-63. doi: 10.1007/BF03189686.
6
Differential transplacental binding of valproic acid: influence of free fatty acids.丙戊酸的胎盘差异结合:游离脂肪酸的影响
Br J Clin Pharmacol. 1984 Jun;17(6):759-62. doi: 10.1111/j.1365-2125.1984.tb02414.x.
7
Pharmacokinetics of valproic acid in the elderly.丙戊酸在老年人中的药代动力学
Br J Clin Pharmacol. 1984 Jun;17(6):665-9. doi: 10.1111/j.1365-2125.1984.tb02401.x.
8
Plasma protein-binding and CSF concentrations of valproic acid in man following acute oral dosing.急性口服给药后人体中丙戊酸的血浆蛋白结合率及脑脊液浓度
Br J Clin Pharmacol. 1983 Oct;16(4):365-9. doi: 10.1111/j.1365-2125.1983.tb02179.x.
9
Free drug concentration monitoring in clinical practice. Rationale and current status.临床实践中的游离药物浓度监测。原理与现状。
Clin Pharmacokinet. 1986 Nov-Dec;11(6):450-69. doi: 10.2165/00003088-198611060-00003.
10
Clinical pharmacokinetics of valproic acid--1988.丙戊酸的临床药代动力学——1988年
Clin Pharmacokinet. 1988 Dec;15(6):367-89. doi: 10.2165/00003088-198815060-00002.